发明名称 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
摘要 The present invention relates to a method of identifying a compound involved in pain, the use of Ctla2b nucleic acid or Ctla2b protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
申请公布号 US8835359(B2) 申请公布日期 2014.09.16
申请号 US201113699976 申请日期 2011.05.24
申请人 Sanofi 发明人 Gebauer Mathias;Michaelis Martin;Ding-Pfennigdorff Danping;Schulte Anke M.;Ziemek Daniel;Metz-Weldmann Christiane
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 Lathrop & Gage LLP 代理人 Lathrop & Gage LLP ;Biro, Esq. Michael G.
主权项 1. A method for identifying a compound involved in neuropathic pain comprising the steps of: a) providing a cell-based system comprising a cytotoxic T lymphocyte-associated protein 2 beta (Ctla2b) nucleic acid encoding a protein comprising the amino acid sequence of either SEQ ID NO: 1 or 2, b) contacting the cell-based system with a test compound, and c) determining an effect of the test compound on the cell-based system, wherein the test compound is identified as a compound involved in neuropathic pain when the test compound causes a statistically significant increase in the level of Ctla2b nucleic acid encoding a protein comprising the amino acid sequence of either SEQ ID NO: 1 or 2 relative to the same cell-based system that was not contacted with the test compound.
地址 Paris FR